Yearly Archives: 2022
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult patients with type 2 diabetes and chronic kidney disease stages 1-3b.
Soft Cell Labs announces new Urinary Tract Infection Test
Soft Cell Labs announces new Urinary Tract Infection Test
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories
ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business
New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology, manufacturing, global capabilities, and iconic brands
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
Senate Democrats Push Drug Pricing, Tax, Climate Package
Sen. Joe Manchin (D-W. Va.) on Wednesday said he had signed off on a revised “Build Back Better” plan, renamed the “Inflation Reduction Act of 2022,” which includes sweeping drug price controls along with tax increases and billions for climate and energy spending. The bill’s drug pricing provisions would allow Medicare to negotiate drug prices […]
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beginning of year projections.
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-0390, an Investigational Emopamil-binding Protein (EBP) Inhibitor for the Treatment of Brain Cancer
Sumitomo Pharma Oncology recently announced the U.S. FDA granted Orphan Drug Designation for DSP-0390, an investigational emopamil-binding protein (EBP) inhibitor for the treatment of brain cancer.
Forbes Magazine Recognizes ARUP Among Nation’s Best Employers for Women
ARUP Laboratories’ ongoing commitment to provide an environment of diversity, inclusion, and belonging for all employees has earned the company recognition as one of Forbes magazine’s Best Employers for Women 2022. The Forbes ranking, first published online on Tuesday, July 26, places ARUP 236th on a list of 300 companies nationwide. Winners were chosen based […]
Published UCLA and Spectrum Saliva Liquid Biopsy Research Highlights Signal Amplifying Ability and Clear Detection of Cancer Biomarkers
Spectrum Solutions announced the publishing of findings from their research collaboration with the University of California at Los Angeles (UCLA) and Dr. David Wong, UCLA School of Dentistry.
Clene’s ALS Drug Increases Survival by 70% in Mid-stage Study
Shares of Clene, Inc. surged Thursday after the company released “golden” data from an interim analysis of a Phase II study.
